These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 15609774)

  • 1. Translational research to assist policy decisions about introducing new vaccines in developing countries.
    Clemens JD; Jodar L
    J Health Popul Nutr; 2004 Sep; 22(3):223-31. PubMed ID: 15609774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Policy analysis: an essential research tool for the introduction of vaccines in developing countries.
    Mahoney R
    J Health Popul Nutr; 2004 Sep; 22(3):331-7. PubMed ID: 15609786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme.
    Kaljee LM; Pack R; Pach A; Nyamete A; Stanton BF
    J Health Popul Nutr; 2004 Sep; 22(3):293-303. PubMed ID: 15609782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of engaging policy-makers at the outset to guide research on and introduction of vaccines: the use of policy-maker surveys.
    DeRoeck D
    J Health Popul Nutr; 2004 Sep; 22(3):322-30. PubMed ID: 15609785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PneumoADIP: an example of translational research to accelerate pneumococcal vaccination in developing countries.
    Levine OS; Cherian T; Shah R; Batson A
    J Health Popul Nutr; 2004 Sep; 22(3):268-74. PubMed ID: 15609779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of typhoid vaccines in Asia: the DOMI experience.
    Ochiai RL; Acosta CJ; Agtini M; Bhattacharya SK; Bhutta ZA; Do CG; Dong B; Chen X; Stanton B; Kaljee L; Nyamete A; Galindo CM; von Seidlein L; DeRoeck D; Jodar L; Clemens JD
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S34-8. PubMed ID: 17582567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paving the way for the introduction of new vaccines into developing countries.
    Chabalgoity JA
    Expert Rev Vaccines; 2005 Apr; 4(2):147-50. PubMed ID: 15889986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation.
    Steele AD; Patel M; Parashar UD; Victor JC; Aguado T; Neuzil KM
    J Infect Dis; 2009 Nov; 200 Suppl 1():S63-9. PubMed ID: 19817616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
    Patel MM; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues in the design and implementation of vaccine trials in less developed countries.
    Deen JL; Clemens JD
    Nat Rev Drug Discov; 2006 Nov; 5(11):932-40. PubMed ID: 17080029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introducing new vaccines in developing countries: concepts and approaches to estimating burden of Haemophilus influenzae type b-associated disease.
    Kilgore PE; Nyambat B
    J Health Popul Nutr; 2004 Sep; 22(3):246-56. PubMed ID: 15609777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia.
    DeRoeck D; Clemens JD; Nyamete A; Mahoney RT
    Vaccine; 2005 Apr; 23(21):2762-74. PubMed ID: 15780724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking new ground--are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents?
    Clements CJ; Abdool-Karim Q; Chang ML; Nkowane B; Esparza J
    Vaccine; 2004 Jul; 22(21-22):2822-6. PubMed ID: 15246617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on better vaccine takes off, as measles deadlines loom. CVI goal: vaccines given earlier in life.
    CVI Forum; 1995 Oct; (10):22-4. PubMed ID: 12290724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing HIV vaccines for developing countries.
    Abrams S
    Harv AIDS Rev; 1995; ():17-9. PubMed ID: 12319991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.